PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Capsaicin - Osteoarthritis
PAD Profile : Capsaicin - Osteoarthritis Important
Keywords :
Capsicum, PNMP, rheumatic disease
Brand Names Include :
Zacin
Important Information :
0.025% cream (Zacin brand) is licensed for this indication.
(0.075% Axsain cream is NOT licensed for osteoarthritis)
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
- Other health supplement preparations
- Piroxicam
- Other health supplement preparations
- Ibuprofen
- Ketoprofen
- Diclofenac sodium
- Felbinac
Other Indications
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
06 June 2018
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
The Surrey and North West Sussex Area Prescribing Committee (APC) during the update of the persistant non-malignant pain guidelines, recommends topical capsaicin (Zacin) as an adjunct to core treatment for knee or hand osteoarthritis in line with NICE guidance CG177.
Please note that the Axsain brand is not licensed for use in osteoarthritis.
Topical capsaicin (Zacin) will be considered GREEN on the traffic light system for this indication
Associated BNF Codes
10. Musculoskeletal and Joint Diseases
10.03.02. Rubefacients, topical NSAIDs, capsaicin and poultices